Dublin, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/smxfm4/neurovascularinte)
has announced the addition of the
"Neurovascular/Interventional Neurology Market [Aneurysm Coils,
Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic
Agents, & Cerebral Angioplasty Balloons] - Global Trends &
Competitive Analysis to 2017" report to their offering.
Neurointerventional radiology or endovascular neurosurgery
refers to special minimally invasive procedures to diagnose and
treat vascular disorders of the brain and spine. With the help of
advanced imaging for guidance, neurointerventionalists or
neurosurgeons use microcatheters (tiny tubes) to treat many complex
disorders. Normally these disorders are treated either by closing
(embolization) or opening (recanalization) the abnormal vessels.
The neurointerventional device market encompasses neurothrombectomy
devices (suction/aspiration device, clot retriever, and snare
device), cerebral angiography and stenting system (carotid stent,
and embolic protection system), aneurysm coiling devices (platinum
coil, liquid embolic agents, and flow diversion device) and support
devices (microcatheter, and microguidewire).
The neurointerventional devices market encompasses
neurothrombectomy devices (suction/aspiration device, clot
retriever, and snare device), cerebral angiography and stenting
system (carotid stent, and embolic protection system), aneurysm
coiling devices (platinum coil, liquid embolic agents, and flow
diversion device) and support devices (microcatheter, and
microguidewire).
The global neurointerventional devices market is estimated to be
$1,248.5 million in 2012 and is expected to grow at a CAGR of 6.8%
to reach $1,733.7 million by 2017. Aneurysm Coiling &
Arteriovenous Malformation Embolization & Fistula embolization
segment accounts for the largest share of the global
neurointerventional devices market, followed by support devices
cerebral balloon angioplasty & stenting systems and
neurothrombectomy devices in 2012.
The major driving factor for these markets involves gradual
technological evolution, growing ageing and obese population,
rising patient pool for ischemic and hemorrhagic stroke and
increasing demand for minimally invasive surgical procedures.
Growing GDP and healthcare allocation are making developing
countries in Asia and Latin America affordable to adapt novel
medical practices for obtaining better treatment outcome. Upcoming
clinical trial data is favoring the interventional procedure over
neurosurgery as it offers limited hospital stays, minimal damage to
surrounding healthy tissues, lesser chances of infection in
post-surgical phase, minimum surgical trauma and lesser surgical
scar.
North America dominates the overall neurointerventional devices
market. Asia-Pacific market including India, China and Japan, and
Latin America market are expected to grow at a higher pace due to
the effect of growing GDP and purchasing capability of healthcare
institutions in those countries. Coiling procedure and flow
diversion have gained popularity in the Asia-Pacific and Latin
American market.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Overview
4 Global Neurointerventional Devices Market, By Techniques
5 Global Neurointerventional Devices Market, By Products
6 Geographic Analysis
7 Competitive Landscape
8 Company Profiles
Companies Mentioned
- Abbott Laboratories
- Bayer Ag
- Coaxia, Inc.
- Covidien, Plc
- Johnson & Johnson
- Merit Medical Systems, Inc.
- Neurointerventional Therapeutics, Inc. (Nit)
- Nfocus Neuromedical, Inc.
- Penumbra, Inc.
- Reverse Medical Corporation
- Stryker Corporation
- Terumo Corporation
- Valor Medical, Inc.
- W.L.Gore & Associates, Inc.
For more information visit http://www.researchandmarkets.com/research/smxfm4/neurovascularinte
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Healthcare and Medical Devices